SAM-e: Difference between revisions
>Penguin007 →Chemistry: Added effect: increased bodily temperature |
>NoNumbersAtTheEnding No edit summary |
||
Line 2: | Line 2: | ||
{{SubstanceBox/SAM-e}} | {{SubstanceBox/SAM-e}} | ||
'''S-Adenosyl-L-methionine''' (also called '''S-Adenosyl methionine''', '''Ademethionine''' and commonly as '''SAMe''' and '''SAM-e''') is a common cosubstrate involved in methyl group transfers, transsulfuration, and aminopropylation in biological organisms.<ref>Homocysteine. | https://www.ncbi.nlm.nih.gov/pubmed/10762063</ref> SAMe is | '''S-Adenosyl-L-methionine''' (also called '''S-Adenosyl methionine''', '''Ademethionine''' and commonly as '''SAMe''' and '''SAM-e''') is a common cosubstrate involved in methyl group transfers, transsulfuration, and aminopropylation in biological organisms.<ref>Homocysteine. | https://www.ncbi.nlm.nih.gov/pubmed/10762063</ref> SAMe is an amino acid methionine bound to an ATP molecule that circulates in the blood naturally and acts as a 'methyl donor'. A methyl group in chemistry is simply a carbon molecule (bound to some hydrogens), and donating a methyl group to other molecules can accelerate or preserve reactions in the body as a form of metabolic 'maintenance'.{{citation needed}} | ||
SAM-e is available over the counter and by prescription in the treatment of depression and osteoarthritis. It is generally distributed in enteric-coated tablets, which allows the supplement to pass through the low pH environment of the stomach to the gastrointestinal tract, raising the bioavaliability by 600%.<ref>Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder. | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156851/</ref> | SAM-e is available over the counter and by prescription in the treatment of depression and osteoarthritis. It is generally distributed in enteric-coated tablets, which allows the supplement to pass through the low pH environment of the stomach to the gastrointestinal tract, raising the bioavaliability by 600%.<ref>Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder. | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156851/</ref> | ||
Line 14: | Line 14: | ||
SAM-e is an [[endogenous]] molecule that has numerous roles including methyl donation in neurotransmitter synthesis, antioxidative effects (radical scavenging, glutathione precursor), anti-inflammatory effects, and neuroprotective effects.<ref>Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. | http://www.ncbi.nlm.nih.gov/pubmed/12420702/</ref> | SAM-e is an [[endogenous]] molecule that has numerous roles including methyl donation in neurotransmitter synthesis, antioxidative effects (radical scavenging, glutathione precursor), anti-inflammatory effects, and neuroprotective effects.<ref>Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. | http://www.ncbi.nlm.nih.gov/pubmed/12420702/</ref> | ||
SAM-e, in addition to providing ATP to the cell, also can convert nicotinamine into N-methyl-nicotinamide (NMNA) via nicotinamide N-methyltransferase, NMNA which can prevent choline efflux from the brain and neuron, a process which may account for some of SAM-e's[[nootropic]] effects.<ref>Nicotinamide homeostasis: a xenobiotic pathway that is key to development and degenerative diseases. | http://www.ncbi.nlm.nih.gov/pubmed/15922112</ref> The involvement of SAM-e in the process of synthesizing serotonin, creatine and dopamine likely play a role in nootropic effects as well. | |||
==Subjective effects== | ==Subjective effects== | ||
Line 29: | Line 29: | ||
*'''[[Effect::Diarrhea]]''' | *'''[[Effect::Diarrhea]]''' | ||
*'''[[Effect::Headaches]]''' | *'''[[Effect::Headaches]]''' | ||
*'''[[Effect::Muscle spasms]]''' | *'''[[Effect::Muscle spasms]]''' | ||
*'''[[Effect::Pain relief]]''' - This appears to be about as effective as NSAIDS such as [[ibuprofen]] for joint inflammation and pain.<ref> Italian double-blind multicenter study comparing S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint disease. | http://www.ncbi.nlm.nih.gov/pubmed/3318442</ref> | *'''[[Effect::Pain relief]]''' - This appears to be about as effective as NSAIDS such as [[ibuprofen]] for joint inflammation and pain.<ref> Italian double-blind multicenter study comparing S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint disease. | http://www.ncbi.nlm.nih.gov/pubmed/3318442</ref> |